Paul Mampilly Says Blockchain May Be In The Cards For Prescription Medication

Home / Paul Mampilly Says Blockchain May Be In The Cards For Prescription Medication

Blockchain is a form of digital record-keeping. It came about in 2008, it helps keep record of tons of transactions and lets people make chronological entries that the public can see. Blockchain creates the viability for cryptocurrencies. Blockchain is very secure. It can’t be hacked and your data is only visible to others if you set the permissions for that. Even if you share your data, you can place restrictions on the way it is available. This makes Blockchain a great preventer of medical fraud, and Paul Mampilly feels that this system will be a real contributor to healthcare.

Blockchain And Our Health

According to Paul Mampilly, blockchain can play a role in your health by letting you know whether or not your medication is working properly. The way this would work is you’d take a pill that has digital sensors. The pill would then send the information to an app on your phone stating whether the correct chemical reactions have happened in your body. This way you can see your doctor for another medication if your medicine was proven ineffective. Another point Paul Mampilly makes is Electronic pills will also let doctors know which patients are taking their medicine properly and which ones are not. Electronic pills could be the root of research, providing data on the effectiveness of several different drugs. The results could be that manufacturers will then have a way to keep improving products.

Technology Is Already Approved

Paul Mampilly says we should keep in mind that there is already an electronic pill out there. It treats schizophrenia and other disorders. The pill is called abilify mycite. It was approved by the FDA in 2017. Medication companies are already looking into possibilities of the e-pill for other drugs. Lots of drug makers feel that this new way to create medication can make the whole process less expensive. They’d have much more ground covered during the research and testing and fine tuning phase. Drug companies could also have the ability to see which patients are taking the medication as instructed. This would give them an ok to leave the medication as is. It is not the fault of the company if someone is not taking the medicine as prescribed.

Read More : banyanhill.com/expert/paul-mampilly/